Major Program
Supportive Care and Symptom Management
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
Wake Forest University Health Sciences
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT03963739
The objective of this study is to examine how adenocarcinoma of the prostate treatment
differentially affects African American men's ability to work and to describe and compare
changes in work ability (as measured through self-reported global work ability item) reported
by African American and white adenocarcinoma of the prostate survivors before treatment and 6
months after treatment completion.
differentially affects African American men's ability to work and to describe and compare
changes in work ability (as measured through self-reported global work ability item) reported
by African American and white adenocarcinoma of the prostate survivors before treatment and 6
months after treatment completion.
Intervention
Interview, Questionnaire Administration
Condition
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage II Prostate Cancer, Stage III Prostate Cancer
Investigators
Joanne Sandberg, Priyank P. Patel, Scott E. Delacroix, Gregory A. Masters, Bryan A. Faller, William P. Fusselman, Robert J. Isaak, Richard L. Deming, David S. Hanson, Kathleen J. Yost, Pamala A. Pawloski, Jay W. Carlson, Jayadev Manikkam Umakanthan, Preston D. Steen, Timothy D. Moore, Chanita Hughes-Halbert, Michael Humeniuk, Robert D. Siegel, Dean A. Delmastro, Gary L. Buchschacher, William J. Irvin, Thomas E. Lad, Bart A. Frizzell, Riccardo Autorino, Stephen J. Ramey, Richard L Deming, Jay W Carlson, Gregory A Masters, Jeffrey L Berenberg, Bryan A Faller, Joshua Lukenbill, Kathleen J Yost, Timothy D Moore, Howard M Gross, David S Hanson, Scott E Delacroix, Kathlee J Yost, Preston D Steen, Pamala A Pawloski, Gopal R Desai, Jason C Lee, Bart A Frizzell, Ki Y Chung, Stephen J Ramey, William J Irvin